Emerging therapeutic agents for advanced non-small cell lung cancer
2020 · Journal of Hematology & Oncology · 365 citations
https://doi.org/10.1186/s13045-020-00881-7
S
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
319
Papers
7.0K
Citations
40
h-index
120
i10-index
Shi H is an academic researcher from Chinese Center For Disease Control and Prevention. The author has contributed to research in topics: Immunotherapy and Immune Responses & RNA Interference and Gene Delivery & Cancer Immunotherapy and Biomarkers. The author has an h-index of 40, co-authored 272 publications.
ORCID: 0000-0002-9958-9892Papers by this author
worksTGF-beta signal transduction: biology, function and therapy for diseases
2022 · Molecular Biomedicine · 134 citations
https://doi.org/10.1186/s43556-022-00109-9
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
2022 · Signal Transduction and Targeted Therapy · 64 citations
https://doi.org/10.1038/s41392-022-01043-6
Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma
2018 · BMC Cancer · 43 citations
https://doi.org/10.1186/s12885-018-5034-x
The Promotion of Erythropoiesis via the Regulation of Reactive Oxygen Species by Lactic Acid
2017 · Scientific Reports · 41 citations
https://doi.org/10.1038/srep38105
Immunosenescence: signaling pathways, diseases and therapeutic targets
2025 · Signal Transduction and Targeted Therapy · 41 citations
https://doi.org/10.1038/s41392-025-02371-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat